Government

WHITE PAPERS AND CASE STUDIES

• CHO Media Screening Success Using Benchmarking Studies

  Explore the challenges of media screening and a straightforward approach for saving time, reducing risks, and improving outcomes.

• Organizational Assessment For A Large MedTech Company

  Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.

• Challenging PFAS-Impacted Industrial Wastewater Reduced To Non-Detect

  ECT2 was approached by a remote refinery in Alaska that had found PFAS in their wastewater stream.

• Ensuring Reliability And Patient Safety With XiltriX

  Protect the integrity of your therapies and ensure patient safety by investing in reliable, real-time environmental monitoring systems that proactively address operational vulnerabilities.

• How LIMS Supports QC Scaling At Forge Biologics

  Modernizing QC workflows with cloud-based systems eliminates paper inefficiencies, reduces errors, and accelerates reporting. Discover how streamlined processes improve compliance and enhance data visibility.

• Scaling With The Client In Mind: A Customer-Centric Approach To Project Scale-Up

  In today’s fast-moving biopharma landscape, scaling from clinic to commercial takes more than expertise. See how collaboration can transform scale-up and drive confident progress

• Navigating Sensitive Country Requirements

  See how Scout expertly navigated complex regional laws and regulations to allow study patients in Iran access to treatment in Turkey.

• Regulatory Considerations For Excipients Used In Lipid Nanoparticles

  Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.

• Deal-Making Volume Slowed In 2023

  This report provides an overview of alliance, merger and acquisition, and financing deal activities across the global biopharma, medical device, and in vitro diagnostics industries in 2023, as reported by Biomedtracker.

• Development And Regulation Of Veterinary Monoclonals

  Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.

• Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection

  Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.

• City Of Lodi Employs GAC To Remove Contaminants From Groundwater

  In this case study, read about AV's unique Concept to Commission approach which enabled a team to design, manufacture, and install GAC systems and interconnecting site pipe in just 10 working hours.